The Size of the Micro Guide Catheters Market in the Asia Pacific is valued at USD 41.91 Million in 2021 and is projected to reach USD 65.51 Million by 2026, increasing at a CAGR of 9.34% during the forecast period 2021 to 2026.
Due to various considerations, such as a higher accuracy rate, lower pain, and fewer infections, the demand for this operation is expanding at a rapid pace. Vascular malformations, uterine fibroids, hyper-vascularized tumors, venal or pulmonary embolism, and arterial embolism can all be treated with micro guide catheters. The hazards connected with this treatment are significantly reduced, resulting in increased patient preferences and, as a result, driving the Asia Pacific micro guide catheter market.
Furthermore, contemporary micro guides offer numerous advantages over traditional catheters, soon boosting the Micro Guide Catheters Market. The micro guide catheters market is being driven by an increase in the rate of neurovascular and cardiovascular disorders in the population and increased demand for procedures due to benefits such as reduced post-surgery complications, shorter hospital stays, and faster recovery and effective recovery bleeding control.
Using these catheters as a material in medical equipment allows for more flexibility and tracking of the stent during surgery, and developments in surgical equipment have increased the market growth of micro guide catheters. The micro guide catheters market is favorably affected by the adoption of unhealthy lifestyle habits, which results in a higher rate of chronic diseases among people and the expanding population and improvement in healthcare infrastructure.
The micro guide catheter is designed to reach exceedingly complex lesions by navigating the most difficult veins, ducts, or cavities in human biology. Because of the sheer number of people getting older and the challenges that come with it, the micro-guide catheters market is expected to increase even more. Furthermore, the material utilized in the catheter's manufacturer allows for flexibility and tracking of the stent during the surgical operation, which boosts the market growth.
The risk of catheter material and function could restrict the Asia Pacific micro guide catheter market's expansion. In addition, the polymer of the catheter is fragile and fractured in some cases. Correction of these fractures necessitates additional surgery, resulting in lower patient compliance and higher operating expenses.
This research report on the Asia Pacific Micro Guide Catheters Market has been segmented and sub-segmented into the following categories.
By Type:
By Therapeutic Area:
By Country:
Geographically, the china micro guide catheters market is projected to expand the growth over the forecast period. Modern disposable catheters are primarily constructed of a polyurethane and are available in various sizes for adults and children.
In addition, most advanced catheters feature a thin hydrophobic surface coating, which is a smooth, slippery film that makes catheter insertion safer and more comfortable. Recently, bio-compatible catheters composed of a polymeric material containing titanium have been employed.
In India micro guide catheters market, the constant advancements in the healthcare industry, and the large population base that the region is projected to boost demand in the Asia Pacific micro guide catheter market. Furthermore, the trend toward more minor invasive surgeries and rising healthcare spending provide lucrative alternatives for micro guide catheters manufacturers.
KEY MARKET PLAYERS
Top Companies leading the Asia Pacific Micro Guide Catheters Market Profiled in the Report are Lake Region manufacturing Inc., Boston Scientific Corporation, Volcano Corporation, Micro Therapeutics Inc., LuMend Corporation, Terumo Europe N.V., Covidien AG, ASAHI INTEC Company Limited, Merit Medical Systems Inc.,
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Over-the-wire micro guide catheter
5.1.3 Flow directed micro guide catheter
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Therapeutic Area
5.2.1 Introduction
5.2.2 Neurovascular
5.2.3 Cardiovascular
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End User
5.3.1 Hospitals
5.3.2 Specialty Clinics
5.3.3 Ambulatory Surgery Centers
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Therapeutic Area
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Therapeutic Area
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Therapeutic Area
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
6.7 Rest of APAC
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 LuMend Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Terumo Europe N.V.
8.3 Covidien AG
8.4 ASAHI INTECC Company Limited
8.5 Lake Region manufacturing Inc.
8.6 Boston Scientific Corporation
8.7 Volcano Corporation
8.8 Micro Therapeutics Inc
8.9 Merit Medical Systems Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
